Medtronic plc (NYSE:MDT) announced today that it has started to inform patients worldwide of a voluntary recall of specific lots of infusion sets used with all models of Medtronic insulin pumps. The recall is related to a certain discontinued component in these infusion sets and does not include insulin pumps or glucose sensors.
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2wVJj1j
via IFTTT
No comments:
Post a Comment